Irina Yushmanova - Search Results

Year	Number of Results
2011	1
2015	1
2016	1
2017	1
2018	1
2019	1
2020	2
2023	5
2024	1

1

Franco I, Hoebeke PB, Dobremez E, Titanji W, Geib T, Jenkins B, Yushmanova I, Austin PF. Franco I, et al. Among authors: yushmanova i. J Urol. 2023 Apr;209(4):783-784. doi: 10.1097/JU.0000000000003157.03. Epub 2023 Apr 1. J Urol. 2023. PMID: 36891836 No abstract available.

2

Pregnancy Outcomes in Patients Exposed to OnabotulinumtoxinA Treatment: A Cumulative 29-Year Safety Update.

Brin MF, Kirby RS, Slavotinek A, Adams AM, Parker L, Ukah A, Radulian L, Elmore MRP, Yedigarova L, Yushmanova I. Brin MF, et al. Among authors: yushmanova i. Neurology. 2023 Jul 11;101(2):e103-e113. doi: 10.1212/WNL.0000000000207375. Epub 2023 May 3. Neurology. 2023. PMID: 37137724 Free PMC article.

3

Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX^®) Treatment from Global Registration Studies across Multiple Indications: A Meta-Analysis.

Jankovic J, Carruthers J, Naumann M, Ogilvie P, Boodhoo T, Attar M, Gupta S, Singh R, Soliman J, Yushmanova I, Brin MF, Shen J. Jankovic J, et al. Among authors: yushmanova i. Toxins (Basel). 2023 May 17;15(5):342. doi: 10.3390/toxins15050342. Toxins (Basel). 2023. PMID: 37235376 Free PMC article.

4

Long-term Safety and Tolerability of Repeated Treatments With OnabotulinumtoxinA in Children With Neurogenic Detrusor Overactivity.

Franco I, Hoebeke PB, Dobremez E, Titanji W, Geib T, Jenkins B, Yushmanova I, Austin PF. Franco I, et al. Among authors: yushmanova i. J Urol. 2023 Apr;209(4):774-784. doi: 10.1097/JU.0000000000003157. Epub 2023 Jan 19. J Urol. 2023. PMID: 36655470 Clinical Trial.

5

Pregnancy outcomes following exposure to onabotulinumtoxinA.

Brin MF, Kirby RS, Slavotinek A, Miller-Messana MA, Parker L, Yushmanova I, Yang H. Brin MF, et al. Among authors: yushmanova i. Pharmacoepidemiol Drug Saf. 2016 Feb;25(2):179-87. doi: 10.1002/pds.3920. Epub 2015 Dec 4. Pharmacoepidemiol Drug Saf. 2016. PMID: 26635276 Free PMC article.

6

Safety and Stability of Pulmonary Function in Patients with Decreased Respiratory Function Treated for Spasticity with OnabotulinumtoxinA.

Ayyoub Z, Brashear A, Banach M, Schoene R, Stringer W, Boodhoo T, Yushmanova I, Dimitrova R, Brin MF. Ayyoub Z, et al. Among authors: yushmanova i. Toxins (Basel). 2020 Oct 19;12(10):661. doi: 10.3390/toxins12100661. Toxins (Basel). 2020. PMID: 33086749 Free PMC article. Clinical Trial.

7

Safety of OnabotulinumtoxinA with Concomitant Antithrombotic Therapy in Patients with Muscle Spasticity: A Retrospective Pooled Analysis of Randomized Double-Blind Studies.

Dimitrova R, James L, Liu C, Orejudos A, Yushmanova I, Brin MF. Dimitrova R, et al. Among authors: yushmanova i. CNS Drugs. 2020 Apr;34(4):433-445. doi: 10.1007/s40263-020-00709-5. CNS Drugs. 2020. PMID: 32170665 Free PMC article.

8

Safety and tolerability of onabotulinumtoxinA in the treatment of upper facial lines from global registration studies in 5298 participants: A meta-analysis.

Brin MF, De Boulle K, Liew S, Carruthers A, Carruthers J, Rivkin A, Wu Y, Kawashima M, Yushmanova I, Boodhoo TI, Lee E. Brin MF, et al. Among authors: yushmanova i. JAAD Int. 2023 Sep 9;14:4-18. doi: 10.1016/j.jdin.2023.07.021. eCollection 2024 Mar. JAAD Int. 2023. PMID: 38035126 Free PMC article.

9

Phase 3 Study of OnabotulinumtoxinA Distributed Between Frontalis, Glabellar Complex, and Lateral Canthal Areas for Treatment of Upper Facial Lines.

De Boulle K, Werschler WP, Gold MH, Bruce S, Sattler G, Ogilvie P, Street J, Larsen KE, Yushmanova I, Lei X, Lee E, Vitarella D, Mao C. De Boulle K, et al. Among authors: yushmanova i. Dermatol Surg. 2018 Nov;44(11):1437-1448. doi: 10.1097/DSS.0000000000001612. Dermatol Surg. 2018. PMID: 30096106 Clinical Trial.

10

Real-World Safety And Effectiveness Of OnabotulinumtoxinA Treatment Of Crow's Feet Lines And Glabellar Lines: Results Of A Korean Postmarketing Surveillance Study.

Yi DJ, Hwang S, Son J, Yushmanova I, Anson Spenta K, St Rose S. Yi DJ, et al. Among authors: yushmanova i. Clin Cosmet Investig Dermatol. 2019 Nov 19;12:851-856. doi: 10.2147/CCID.S227493. eCollection 2019. Clin Cosmet Investig Dermatol. 2019. PMID: 31819582 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year